Our Team
Our investment management team has more than 50 years of investment experience with a dedicated focus on communications, healthcare and sustainability. The team is supported by the Advisory Council which comprises world-leading scientific and business experts, and by an external pool of specialist managers and consultants.
Click on the images below for individual biographies...or click here to view a list of team members

Edward Mott
Chief Executive
David Mott
Investment Director
Andrew Sherlock
Investment Director
Colin Watts
Investment Director - Communications
David Brister
Operating Partner
Alex Tancock
Operating Partner, Asia Office
Martin Smith
Non-Executive Director
Robin Hill
Director
Åsa Blidegård
Investment Adviser, Swiss Office
Alastair Stewart
Investment Manager
Sebastian Miller
Investment Analyst
James Faulkner
Manager, Private Clients
Lucy Foster
Head of Investor Services and Communications
Will LawsManager, Investor Services

John Gale
Investor Services Assistant
Lucy DightonHead of Operations and Finance

Claire Ritchie
Executive & Communications Assistant
Rachel Guest
Office Assistant
Emma Palmer-Foster
Portfolio Consultant
Chris Mallows
Investment Adviser
Our Team
- Alastair Stewart, Investment Manager
- Alex Tancock, Operating Partner, Asia Office
- Andrew Sherlock, Investment Director
- Åsa Blidegård, Investment Adviser, Swiss Office
- Chris Mallows, Investment Adviser
- Claire Ritchie, Executive & Communications Assistant
- Colin Watts, Investment Director - Communications
- David Brister, Operating Partner
- David Mott, Investment Director
- Edward Mott, Chief Executive
- Emma Palmer-Foster, Portfolio Consultant
- James Faulkner, Manager, Private Clients
- John Gale, Investor Services Assistant
- Lucy Dighton,
Head of Operations and Finance
- Lucy Foster, Head of Investor Services and Communications
- Martin Smith, Non-Executive Director
- Rachel Guest, Office Assistant
- Robin Hill, Director
- Sebastian Miller, Investment Analyst
- Will Laws,
Manager, Investor Services

Edward Mott
Chief Executive
Edward co-founded Oxford Capital in 1999 with the intent of extending private equity growth capital to wealthy families as well as to institutional investors. He chairs the Investment Committee at Oxford Capital. With over 30 years of experience as a practical manager, investor and business leader, Ted has worked with both mature listed businesses and younger high growth companies across a multitude of sectors. Following an early career in the US with Corning Glass Inc where he was involved with the first commercialisation of fibre optics, he then pursued a career in investment banking with American, European and Asian banks in corporate finance, emerging markets and structured finance, before heading HSBC Group’s capital markets division based in Hong Kong. He later served the wealth manager GAM in London before founding Oxford Capital. Ted is a graduate of the University of Cambridge and an INSEAD MBA and is fluent in French and German. Ted is also a keen sailor and gardener.

David Mott
Investment Director
David co-founded Oxford Capital. He leads the firm’s investment and portfolio management activities and is a member of the Investment Committee. During his career as an investment manager, he has led numerous investment and exit transactions, including both IPOs and acquisitions. His investment focus is on the sustainability sector in which he targets investments in renewable energy, waste management, environmental solutions and process efficiency. He previously worked with Result Ventures where he specialised in supporting technology companies in their international expansion. Prior to this he worked with PricewaterhouseCoopers in corporate finance. His early career was as an equity analyst with Jardine Fleming in Asia and later with Deloitte and Touche in London where he trained as an accountant. David has a BA in Economics and Japanese from the University of Durham and speaks French, German and Japanese. David is a passionate collector of contemporary art and regularly competes in triathlons.

Andrew Sherlock
Investment Director
Andrew has over 15 years of experience in quoted smaller companies with Cazenove, Goldman Sachs and latterly as a Managing Director at Dresdner Kleinwort, where he was Head of Small Cap Equities and responsible for all aspects of research and sales. Previously Andrew qualified as a chartered accountant with PricewaterhouseCoopers and subsequently worked for a number of years in industry with Mars in Russia and Procter & Gamble in the UK. Andrew read Economics and Politics at the University of Durham. He enjoys travel, theatre and sport.

Colin Watts
Investment Director - Communications
Colin is responsible for investments in the information and communications sectors. He brings to the team a combination of deep market knowledge gained in the telecoms industry and extensive international transactional experience gained as a corporate investor and as a partner of two international venture capital firms. Previously Colin has held investment management positions with Cisco Systems Inc, DFJ ePlanet and TLcom Capital where he invested over $80 million across 12 companies in Europe and Israel. This portfolio achieved 4 IPO’s and 6 M&A transactions worth in excess of $4.5bn. Colin graduated from Nottingham University with first class honours in Electrical and Electronic Engineering. Colin has sailed across the Atlantic.

David Brister
Operating Partner
David assists with new investments and contributes to the development of portfolio companies with a focus on healthcare and life sciences. David has over 20 years experience in both private equity and in operational roles and was instrumental in the successful development of venture capital businesses at 3i and MVM. During that time he was responsible for many successful investments and exits including Cambridge Antibody Technology (listed in 1997 and acquired by AstraZeneca for £702m), Acambis (listed in 1995 and acquired by Sanofi Pasteur for £276m) and Oxford GlycoSciences (listed in 1998 and acquired by Celltech for £102m) and was chairman of Domantis (acquired by GlaxoSmithKline for £230m). More recently he was Chief Business Officer and a member of the executive management team that transformed Evotec (listed on NASDAQ and the Frankfurt Stock Exchange) through a series of M&A transactions. David is currently Chairman or Non-Executive Director of several high growth life science and technology companies. David holds a BSc in Genetics & Zoology from Sheffield University.

Alex Tancock
Operating Partner, Asia Office
Alex is an Operating Partner at Oxford Capital and assists with the firm’s Chinese and Asian activities. Based in Hong Kong, his role is primarily focused on business development activities for both portfolio companies and servicing investors in Oxford Capital’s funds. Alex is an experienced entrepreneur and business operator with extensive experience in the Asian markets and a track record of building value for European companies expanding into the region. Most recently Alex has been the project manager of Asia’s first offshore wind farm development and has advised on over £1bn of renewable energy investments across the Asia-Pacific Region. He graduated from Imperial College with a BSc in Theoretical Physics and holds an ACCA Diploma in Financial Management.

Martin Smith
Non-Executive Director
Martin has been involved in investment management and investment banking for over 30 years. He founded and later chaired the investment banking and private equity firm Phoenix Securities. After the sale of Phoenix, he became chairman of DLJ’s European Investment Banking Group. He subsequently co-founded New Star Asset Management and was a senior advisor to Bain Capital. He is currently chairman of GP Bullhound and co-founder of Beaumont Partners. His family Foundation has created and endowed the Smith School for Enterprise and the Environment at Oxford University. Martin has a wide variety of interests in the Arts.

Robin Hill
Director
Robin is a member of the Oxford Capital Investment Committee. He is a chartered accountant and an experienced executive, director, consultant and company doctor, specialising in advising companies in change situations, most recently including high technology companies in the communications and digital equipment industries. He has led an international career in the USA, Europe and Australia. He was President of Spembly Inc in California, a US medical devices company, for which he built the North American marketing operation. He has since been Special Adviser to a large digital media company, Director of the Pharmaceutical Society of Great Britain, CFO of a major international professional services firm and Adviser to World Bank projects. Outside the office Robin is a history scholar.

Åsa Blidegård
Investment Adviser, Swiss Office
Åsa is responsible for building and supporting Oxford Capital's relationships with international investors. A specialist in biotechnology and healthcare, Åsa previously gained experience in marketing technology management and healthcare as Director of Medtronic and Serono International, and went on to be Director of Arlington Group Limited, in the UK, where she established Arlington Diversified Capital. Åsa graduated from the University of Lund and later gained an MBA from Cranfield University, enabling her to combine scientific expertise with business insight.

Alastair Stewart
Investment Manager
Alastair is responsible for sourcing, executing and monitoring investments in the TMT and cleantech sectors. He has over four years' experience investing in growth-stage technology companies. Prior to joining Oxford Capital Alastair worked in the technology division of mobile operator O2. Alastair is a Chartered MCSI and holds an Engineering degree from Magdalen College, Oxford, where he spent a great deal of time rowing and also made an appearance on University Challenge. In his spare time he enjoys photography and playing the piano.

Sebastian Miller
Investment Analyst
Sebastian is part of the investment management team, sourcing and screening potential deals across the communications, healthcare and sustainability sectors. He received a BA in Economics & Management from New College, Oxford and has done research in the Saïd Business School for papers in the field of Strategic Management. Outside of the office, Sebastian is studying for the CFA, is a keen chef and enjoys travelling with sub-Saharan Africa his next target.

James Faulkner
Manager, Private Clients
James is responsible for strengthening and extending Oxford Capital’s fundraising capability and works principally with our private investors and their advisors. With over 20 years experience of business development and relationship management, James most recently worked with PricewaterhouseCoopers.
James has a Diploma in Business Administration & Management from the Open University Business School. In his spare time, when he’s not walking the family dog, James enjoys keeping fit and regularly competes in triathlons

Lucy Foster
Head of Investor Services and Communications
Lucy is responsible for Investor Services and is also responsible for marketing and communications. Previously Lucy worked at Ennismore Fund Management, a hedge fund investing in European smaller companies. Lucy began her career working in private client services at Union Bancaire Privee and Morgan Stanley. Lucy graduated from Durham University with a BA in French. In her spare time Lucy enjoys playing tennis and golf and is a keen skier.

Will Laws
Manager, Investor Services
Will is responsible for Investor Services and communications and works within the marketing team. He started his career with PricewaterhouseCoopers, where he qualified as a chartered accountant before moving into business development. He then joined the research team of Fast Track, an Oxford company which publishes league tables of fast-growth businesses in The Sunday Times. Most recently, he worked as commercial manager for the communications technology company Wireless Logic. He has a philosophy degree from the University of Durham, and outside work his interests including running, reading and cinema.

John Gale
Investor Services Assistant
John is responsible for private client services and assists with corporate marketing and communications. He graduated in Engineering from Brookes University in Oxford and has a background in administrative support and customer service. John’s interests outside the office include climbing, hill-walking and photography.

Lucy Dighton
Head of Operations and Finance
Lucy coordinates the resources of the firm through managing the operations, administration, finance, technology and compliance functions. Lucy trained as a healthcare analyst with Oxford Capital and previously gained experience in technology management with Synaptics UK, a spin-off from Scientific Generics in Cambridge. Lucy graduated from the University of Oxford with a BA in Physiological Sciences and is a chartered member of the Institute for Securities and Investment. In her spare time Lucy enjoys working on her allotment and scuba diving.

Claire Ritchie
Executive & Communications Assistant
Claire’s role is to provide support to the Directors, as well as assisting the Investor Services and Marketing teams. She graduated in Spanish and Marketing from the University of Stirling and also studied Marketing and Business at the University of Cantabria in Northern Spain. Claire’s interests outside of the office include archaeology, translation and music.

Rachel Guest
Office Assistant
Rachel assists the investment management team and provides office management support, working alongside Claire Ritchie. She graduated from York University with a Masters degree in Public Administration and Public Policy and a BA Hons in Politics. Her interests outside the office include going to the theatre and cooking.

Emma Palmer-Foster
Portfolio Consultant
Emma contributes to the monitoring and development of portfolio companies with a focus on healthcare. She has over 15 years’ experience in the European healthcare sector, via roles in investment banking, technology transfer, and investor relations. She works with a wide range of clients and advises companies on corporate and financial strategy, investor relations and communications. Emma has an MA in Biochemistry from the University of Oxford and an MBA from the University of Durham. She is also a Trustee of the mental health charity MPF Counselling and a Visiting Fellow at Durham Business School.

Chris Mallows
Investment Adviser
Chris is an adviser to Oxford Capital and is a member of the Investment Committee. He brings to the team international experience of financial transactions and technology implementation in complex organisations. Chris has had an international career in investment banking and the securities industry. Following an early career with Cazenove and Panmure Gordon, he joined stockbrokers Rowe and Pitman where he was a partner. He later became a director at Warburg Securities in London and in 1994 was appointed Chief Executive of Standard Chartered Securities. Chris is a Fellow of the Chartered Institute for Securities and Investment.
Latest Blog Posts
Our news
Portfolio news
Print this page | Font size: - +


Email Edward Mott
Join Edward Mott on LinkedIn